Skip to content

Rotational Thromboelastometry Activated Transfusion In Trauma Trial

Viscoelastic Guided Goal Directed Resuscitation of Severely Injured Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03765866
Acronym
ROTATE-IT
Enrollment
31
Registered
2018-12-05
Start date
2016-05-31
Completion date
2018-12-17
Last updated
2020-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trauma

Keywords

rotational thromboelastometry, viscoelastic test, coagulopathy, trauma, hemorrhage

Brief summary

This is a randomized controlled trial to compare viscoelastic (VE) guided resuscitation to fixed-ratio resuscitation in trauma patients with hemorrhagic shock on the utilization of blood products, effects on coagulation and inflammatory mediators, and how these strategies affect post resuscitation adverse events.

Detailed description

This is an open labeled study as the VE guided resuscitation will be based on the visible VE results. Aim 1 will compare the number of blood products utilized in each resuscitation strategy. Aim 2 will analyze the coagulation and inflammatory mediators in each resuscitation strategy to determine if there is a difference in the mechanism of coagulopathy. Aim 3 will determine if the different resuscitation strategies have an effect on post resuscitation adverse events.

Interventions

PROCEDUREThromboelastometry guided transfusion

Comparing resuscitation strategies with standard MTP v.s. ROTEM guided MTP

Sponsors

University of Texas Southwestern Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
14 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

1. Trauma patient 2. MTP Activation 3. Only patients ≥ 14 years old 4. Alive at 31 mins after arrival in ED

Exclusion criteria

1. Transfer from OSH 2. Received CPR for more than 5 mins 3. Burned 4. Pregnant or Prisoner 5. Known DNR 6. Jehovah's witness

Design outcomes

Primary

MeasureTime frameDescription
Change in number of blood products utilized at 24 hours24 hours from time of randomizationNumber of blood products utilized during that time frame will be recorded to determine if change in resuscitation strategies result in measurable differences

Secondary

MeasureTime frameDescription
Change in coagulation profile0 hours and 30 daysAnalyze coagulation profiles in each resuscitation strategy to determine if there is a change in the mechanism of coagulopathy
Change in inflammatory mediators0 hours and 30 daysAnalyze inflammatory mediators in each resuscitation strategy to determine if there is a change in the mechanism of coagulopathy
Changes in Resuscitation strategy-related adverse events30 days after admissionRate of resuscitation strategies-related adverse events as a composite, including (transfusion related acute lung injury, transfusion associated circulatory overload, hyperkalemia, hypocalcemia, allergic reaction, hemolysis and transfusion transmitted infection)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026